Moderna stock falls following new RSV vaccine efficacy data

28,422 次觀看・9 個月前

Moderna (MRNA) shares are dropping after the pharmaceutical giant released the efficacy data for its RSV vaccine. Yahoo Finance breaks examine the reported long-term effectiveness of Moderna's latest vaccine in development.

For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.

Editor's note: This article was written by Luke Carberry Mogan.